What are the benefits of intensive risk-reduction therapies for patients with established coronary and other atherosclerotic vascular disease?
The benefits of intensive risk-reduction therapies for patients with established coronary and other atherosclerotic vascular diseases include improved survival, reduced recurrent events, the need for revascularization procedures, and improved quality of life. Comprehensive risk factor management also reduces risk as assessed by a variety of outcomes.